Corcept Therapeutics Incorporated (NASDAQ:CORT) said on Thursday that it presented results from its Phase 2 DAZALS study of ...

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of ...

UC Irvine researchers conducted a study to better understand the molecular basis of amyotrophic lateral sclerosis (ALS), a ...

Prescribed use of anti-anxiety drugs, hypnotics and sedatives, or antidepressants was tied to a higher future risk of ...

Corcept Therapeutics has tried to cast its recent phase 2 amyotrophic lateral sclerosis (ALS) failure in a more flattering ...

Corcept Therapeutics' dazucorilant failed the primary ALS trial goal but showed improved survival outcomes and a safe profile ...

UC Irvine researchers conducted a study to better understand the molecular basis of amyotrophic lateral sclerosis (ALS), a ...

Amylyx Pharmaceuticals ( NASDAQ: AMLX) said on Tuesday that the U.S. FDA has granted fast track status to its antisense RNA, ...

LANSING, Mich. — The Michigan Department of Health and Human Services (MDHHS) has introduced a new rule requiring mandatory ...

Brainstorm tapped Minaris to manufacture NurOwn for its upcoming Phase 3b clinical trial testing the treatment for ALS.

As the global population ages, the risk of developing neurodegenerative diseases such as dementia, Alzheimer's disease, ...

As the global population ages, the risk of developing neurodegenerative diseases such as dementia, Alzheimer's disease, ...